艾昆纬-2025年医药交易年度回顾-一个更精简但价值更高的交易年(英)-2026
聚焦艾昆纬-2025年医药交易年度回顾-一个更精简但价值更高的交易年(英)-2026。Introduction–12%DECLINE IN DEALS;Aggregate spending on M&A surged by 99% to US$257 B, with nine acquisitions exceeding the US$10 B mark.
聚焦艾昆纬-2025年医药交易年度回顾-一个更精简但价值更高的交易年(英)-2026。Introduction–12%DECLINE IN DEALS;Aggregate spending on M&A surged by 99% to US$257 B, with nine acquisitions exceeding the US$10 B mark.
聚焦艾昆纬-2025年医药交易年度回顾-一个更精简但价值更高的交易年(英)-2026。Introduction–12%DECLINE IN DEALS;Aggregate spending on M&A surged by 99% to US$257 B, with nine acquisitions exceeding the US$10 B mark.
聚焦艾昆纬-2025年医药交易年度回顾-一个更精简但价值更高的交易年(英)-2026。Introduction–12%DECLINE IN DEALS;Aggregate spending on M&A surged by 99% to US$257 B, with nine acquisitions exceeding the US$10 B mark.
覆盖 2026 年,全文共 21 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了医药、艾昆纬、2025年医药交易年度回顾、一个更精简但价值更高的交易年等议题。